A risk model based on data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (ACSD) can accurately ...

Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following ...

Among a group of high-risk patients who developed infective endocarditis (IE) after transcatheter aortic valve implantation, cardiac surgery failed to improve clinical outcomes when compared with ...

Objective Multidisciplinary team (MDT) meetings are central to treatment decisions in aortic stenosis (AS), particularly for borderline or high-risk patients. This study evaluates long-term, ...

Aortic stenosis (AS) is a progressive heart valve disease that leads to the narrowing of the aortic valve opening, restricting blood flow from the heart to the rest of the body.

LONDON — Continuing oral anticoagulant drugs rather than briefly stopping them during transcatheter aortic valve implantation (TAVI) failed to provide any benefits and, in fact, increased the risk for ...

TAVI has transformed treatment for patients who are too weak for open-heart surgery. It offers faster recovery, fewer complications, and a chance at a better quality of life. For decades, severe ...

What follows is an outsider's report on the next big phase of cardiology—the percutaneous treatment of valvular heart disease. I have little doubt that in 5 to 10 years, transcutaneous valves will be ...

Findings from the PARTNER 2 randomized trial indicate that transcatheter aortic valve implantation (TAVI) is noninferior to surgical aortic valve replacement (SAVR) in intermediate-risk patients with ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that involves replacing the aortic valve in people with aortic stenosis. It has several benefits over open heart surgery ...